Oxaliplatin is a platinum-based antineoplastic agent used in cancerchemotherapy. It is used for treatment of colorectal cancer, typically along with folinic acid and 5-fluorouracil in a combination known as FOLFOX. Oxaliplatin has been compared with other platinum compounds used for advanced cancers, such as cisplatin and carboplatin.
Oxaliplatin API has got Chinese local GMP, CEP and TGA. It is also approved by US-FDA.
Oxaliplatin Injection has got MA from US-FDA and Chinese local GMP certificate. 
Oxaliplatin for Injection has got EU-GMP and Chinese local GMP.  It is one of the major products of our company which is mainly used in the first-line therapy of metastatic colorectal cancer and adjuvant therapy of primary tumor completely excised phase III colorectal cancer. Approved to get launched in the European market in August, 2012, Oxaliplatin for injection is the first injection product of domestic pharmaceutical enterprises approved to get launched in the European market.